About Atavistik Bio
Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Our approach enables selective modulation of disease-causing proteins, with the potential to offer transformative treatment for patients with serious diseases.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $40,000,000 · Series-B+
GlobeNewswire
- Capital Raise
Raised $120,000,000 · Series-B+
fundraisingfox.com
- Milestone
X account created (@AtavistikBio)
54 followers
- Capital Raise
Raised $60,000,000 · Series-A
- Milestone
Website domain registered
atavistikbio.com
Investors & Backers
Funding History
Founders & Leadership
Aninda Katragadda
Chief Financial Officer
Bryan Stuart
Chief Executive Officer
Jared Rutter
Founder
John Josey
Acting Chief Executive Officer
Marion Dorsch
President and Chief Scientific Officer
Ralph J DeBerardinis
Founder
Press Coverage & Sources
news.google.com/rss/articles/CBMipgJBVV95cUxPdWF0Nl9abTNJMkxDWlFBWnJnYnl4NEt4MW1kN21IWTZIWDVFclNEdzNCdlJWSkxReDhpOHZxMVh3bmZ3TmRkcGhCd3JDZU16WlZTY2tjV3NQSzlsMUV1OUptU2FwYzBEeDIta0Q0QnMxS2MwRmUtbjJwT0ZCYlJQTi1pTTIyZDBSRVUybm5sQThtaHZFV0pVdi16RkhEc2toUmpMbXVzVms2WVN6Znp6RXlTQ0M1dG5LWGQyR0pHU0hqUTlvQl8taHlfejZpUkNMUWU4T1NrRWVaUld0NE1nOFgxU3ROWENNejQ3d1RZRVVwbTkwNzBDLXc3SjBoWlVKX0wya1IyRm1IMUUtNWFCS1pkNXdPMFRoNk90MGlZZFBpTTM5ZkE
fundraisingfox.com/companies/atavistik-bio
finsmes.com/2021/08/atavistik-bio-raises-60m-in-series-a-financing.html
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com